ENDOWMENT CASE FUNDING | 5
Impact of your gift By investing in the MRF’s endowment, you will be leveraging your support with that of others to accelerate research progress. As a result, you will:
5
SUPPORT the FDA drug-approval pathway 4
CREATE better outcomes for patients
CREATE clinical trial opportunities 3
FOSTER scientific collaborations between Breakthrough Consortium members to expand knowledge and expertise in the field 2
INCREASE the number and amount of grants awarded annually 1
2018
FDA approves the first combination targeted therapy for adjuvant therapy of BRAF mutant melanoma.
Made with FlippingBook Ebook Creator